Disclosures for "Neighborhood Disadvantage and Outcomes Following Intracerebral Hemorrhage ")
-
Ms. Kim has nothing to disclose.
-
Ms. Kitlen has nothing to disclose.
-
Mr. Torres-Lopez has nothing to disclose.
-
Mr. Rivier has nothing to disclose.
-
Dr. Renedo has nothing to disclose.
-
Ms. Schlechter has nothing to disclose.
-
Ms. Kleinberg has nothing to disclose.
-
Ms. Pish has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Twill Therapeutics.
-
Mr. Kampp has nothing to disclose.
-
Sara Jasak has nothing to disclose.
-
Dr. Sansing has nothing to disclose.
-
Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell. Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zoll. Dr. Sheth has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NControl. Dr. Sheth has received stock or an ownership interest from Astrocyte. Dr. Sheth has received stock or an ownership interest from Alva. The institution of Dr. Sheth has received research support from Biogen. The institution of Dr. Sheth has received research support from Novartis. The institution of Dr. Sheth has received research support from Bard. The institution of Dr. Sheth has received research support from Hyperfine. Dr. Sheth has received intellectual property interests from a discovery or technology relating to health care.
-
The institution of Dr. Falcone has received research support from NIH. The institution of Dr. Falcone has received research support from AHA.